Bayer said Wednesday that it will pay up to $10.9 billion to settle litigation over the weedkiller Roundup, which has faced thousands of lawsuits over claims it causes cancer.
Read More
In launching Oerth Bio under the direction of CEO John Dombrowsky, who formerly led the AgTech Accelerator in RTP, Bayer and partner Arvinas outlined an aggressive agtech agenda.
Read More
Pairwise, a gene editing startup focused on crop science that move its headquarters to Durham from San Diego earlier this year, is reporting progress in its $100 million development deal with Bayer.
Read More
A federal jury has awarded $80 million to a California man after determining that Monsanto’s popular weedkiller, Roundup, was a substantial factor in causing his cancer, and that the corporation is liable. Bayer, which bought Monsanto, says it will appeal.
Read More
Shares in Germany’s Bayer have plunged after a U.S. jury found the Roundup weed killer was a substantial factor in a California man’s cancer — the second case that has gone against manufacturer Monsanto, acquired by Bayer last year.
Read MoreBASF has closed its huge $9 billion purchase of businesses and assets from Bayer, moving four facilities and more than 360 former Bayer employees into the fold of BASF’s Research Triangle Park operations.
Read More
Bayer AG has agreed to the U.S. government’s demand that it sell about $9 billion in agriculture businesses as condition for acquiring Monsanto.
Read More
With a round of 20 new grants, the $500,000 “Feed a Bee” grant program from Bayer has now reached 39 states.
Read More
